image
Bicycle Therapeutics plc BCYC
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 21.79
-3.5 %
$ 1.5 B
Market Cap
-6.64
P/E
CASH FLOW STATEMENT
-60.6 M OPERATING CASH FLOW
29.59%
Growth Rates
1Year 29.59%
3Years -50.49%
5Years -18.38%
7Years -27.18%
10Years 0.00%
-2.93 M INVESTING CASH FLOW
84.57%
Growth Rates
1Year 84.57%
3Years -34.64%
5Years -19.82%
7Years -42.68%
10Years 0.00%
250 M FINANCING CASH FLOW
3636.21%
Growth Rates
1Year 3636.21%
3Years 58.46%
5Years 57.95%
7Years 47.10%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Bicycle Therapeutics plc
image
Net Income -181 M
Depreciation & Amortization 6.55 M
Capital Expenditures -2.93 M
Stock-Based Compensation 32.5 M
Change in Working Capital 77 M
Others 67.2 M
Free Cash Flow -63.6 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (180.7) (112.7) (66.8) (51.0) (30.6) (21.8) (16.3) (13.5)
Depreciation & Amortization 6.5 3.7 1.4 1.3 1.0 0.7 0.3 0.3
Deferred Income Tax 3.3 (5.0) (1.7) (0.7) 0 0 0.1 0
Stock Based Compensation 32.5 26.8 12.1 6.5 3.1 1.0 0.5 0.1
Other Operating Activities 0.7 0.4 2.1 0.8 5.4 0.7 0.9 0.2
Change in Working Capital 77.0 0.7 38.1 25.4 (7.4) (6.6) 13.0 1.9
Cash From Operations (60.6) (86.1) (14.8) (17.8) (28.6) (26.1) (1.4) (11.3)
INVESTING CASH FLOW
Capital Expenditures (2.9) (19.0) (2.0) (1.2) (1.6) (1.2) (1.1) (0.2)
Other Items 0 0 0 0 0 0 0 0
Cash From Investing Activities (2.9) (19.0) (2.0) (1.2) (1.6) (1.2) (1.1) (0.2)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 (0.6) 0 0
Total Debt Repaid 0 0 15.0 15.0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 0.7 1.0 7.2 (0.3) 1.5 26.0 57.9 16.8
Cash From Financing Activities 250.0 6.7 320.7 62.8 58.4 25.4 57.9 16.8
CHANGE IN CASH
Net Change In Cash 187.8 (99.5) 302.7 43.9 28.7 (4.3) 58.3 3.5
FREE CASH FLOW
Free Cash Flow (63.6) (105.1) (16.8) (19.0) (30.2) (27.3) (2.5) (11.5)